FDA 483 data is just the tip of the iceberg
AboutBlogFDA EmployeeOver 40,000+ FDA inspection documents: 483s, EIRs, 483Rs

EIR GlaxoSmithKline Biologicals SA, Dec 2007

$1,190 - Available for instant download

FDA investigators audited the GlaxoSmithKline Biologicals SA - Rixensart, Belgium facility and issued inspectional observation (via FDA 483) on 13 Dec 2007.

Product Details

  • Inspection end: 13 Dec 2007
  • Location: Rixensart, Belgium
  • FEI: 3002875226
GlaxoSmithKline Biologicals SA FDA inspection 483 Dec 2007

Related Products